Dean Y Li Insider Trading $RXRX RECURSION PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Dean Y Li.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Dean Y Li. Dean Y Li is Executive VP & President, MRL in Merck & Co., Inc. ($MRK) and Director in RECURSION PHARMACEUTICALS, INC. ($RXRX).
Dean Y Li in RECURSION PHARMACEUTICALS, INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Dean Y Li: Director
Holdings: 1,422,048 shares
Latest Transaction: Apr 22 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Dean Y Li in RECURSION PHARMACEUTICALS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 22 2021 | RXRX | RECURSION PHARMACE ... | Li Dean Y | Director | Option Exercise | C | 0.00 | 32,685 | 0 | 0 | |
| Apr 22 2021 | RXRX | RECURSION PHARMACE ... | Li Dean Y | Director | Option Exercise | C | 0.00 | 22,698 | 0 | 0 | |
| Apr 22 2021 | RXRX | RECURSION PHARMACE ... | Li Dean Y | Director | Option Exercise | C | 18.00 | 27,778 | 500,004 | 27,778 | |
| Apr 22 2021 | RXRX | RECURSION PHARMACE ... | Li Dean Y | Director | Option Exercise | C | 18.00 | 27,778 | 500,004 | 0 | |
| Apr 22 2021 | RXRX | RECURSION PHARMACE ... | Li Dean Y | Director | Buy | J | 0.00 | 13,889 | 0 | 596,390 | 582.5 K to 596.4 K (+2.38 %) |
| Apr 22 2021 | RXRX | RECURSION PHARMACE ... | Li Dean Y | Director | Sell | J | 0.00 | 13,889 | 0 | 0 | 13.9 K to 0 (-100.00 %) |
| Apr 22 2021 | RXRX | RECURSION PHARMACE ... | Li Dean Y | Director | Buy | J | 0.00 | 582,501 | 0 | 582,501 | 0 to 582.5 K |
| Apr 22 2021 | RXRX | RECURSION PHARMACE ... | Li Dean Y | Director | Sell | J | 0.00 | 582,501 | 0 | 0 | 582.5 K to 0 (-100.00 %) |
| Apr 22 2021 | RXRX | RECURSION PHARMACE ... | Li Dean Y | Director | Buy | J | 0.00 | 1,350,000 | 0 | 1,350,000 | 0 to 1.4 M |
| Apr 22 2021 | RXRX | RECURSION PHARMACE ... | Li Dean Y | Director | Sell | J | 0.00 | 1,350,000 | 0 | 0 | 1.4 M to 0 (-100.00 %) |
| Apr 22 2021 | RXRX | RECURSION PHARMACE ... | Li Dean Y | Director | Buy | J | 0.00 | 450,000 | 0 | 450,000 | 0 to 450 K |
| Apr 22 2021 | RXRX | RECURSION PHARMACE ... | Li Dean Y | Director | Sell | J | 0.00 | 450,000 | 0 | 0 | 450 K to 0 (-100.00 %) |
| Apr 22 2021 | RXRX | RECURSION PHARMACE ... | Li Dean Y | Director | Buy | J | 0.00 | 1,422,048 | 0 | 1,422,048 | 0 to 1.4 M |
| Apr 22 2021 | RXRX | RECURSION PHARMACE ... | Li Dean Y | Director | Sell | J | 0.00 | 1,422,048 | 0 | 0 | 1.4 M to 0 (-100.00 %) |
| Apr 22 2021 | RXRX | RECURSION PHARMACE ... | Li Dean Y | Director | Buy | C | 0.00 | 55,383 | 0 | 1,422,048 | 1.4 M to 1.4 M (+4.05 %) |
| Apr 19 2021 | RXRX | RECURSION PHARMACE ... | Li Dean Y | Director | Option Exercise | A | 18.00 | 27,778 | 500,004 | 27,778 | |
| Apr 19 2021 | RXRX | RECURSION PHARMACE ... | Li Dean Y | Director | Grant | A | 0.00 | 13,889 | 0 | 596,390 | 582.5 K to 596.4 K (+2.38 %) |
Page: 1